National Taiwan University Hospital-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:National Taiwan University Hospital - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014356
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:台湾
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
National Taiwan University Hospital (NTUH) is a healthcare service provider that offers biomedical, clinical research and patient care services. The hospital’s research activities include community-based intervention programs, multicenter controlled clinical trials, program projects, research and development projects, and research training programs. It provides diagnosis and treatment of cancer, hepatitis, and organ transplantation. NTUH develops diagnosis and treatment in the areas of immunology, dermatology, ophthalmology, cardiovascular, infertility, orthopedics and microsurgery. The hospital offers cellular and molecular studies related to normal structure and function. It also promotes international cooperation in order to gain experience and knowledge from the medical development of advanced countries. NTUH is headquartered in Taipei, Taiwan.

National Taiwan University Hospital – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
National Taiwan University Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
National Taiwan University Hospital, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
National Taiwan University Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
National Taiwan University Hospital, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
National Taiwan University Hospital, Medical Devices Deals, 2011 to YTD 2017 9
National Taiwan University Hospital, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
National Taiwan University Hospital, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
National Taiwan University Hospital Forms Joint Venture with SynCore Biotech 11
Parexel International Enters Into Agreement With National Taiwan University Hospital 12
A*STAR Enters Into An Agreement With NTUH And CGMH 13
National Taiwan University Hospital – Key Competitors 14
National Taiwan University Hospital – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Joint Venture 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
National Taiwan University Hospital, Pharmaceuticals & Healthcare, Key Facts 2
National Taiwan University Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
National Taiwan University Hospital, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
National Taiwan University Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
National Taiwan University Hospital, Deals By Therapy Area, 2011 to YTD 2017 8
National Taiwan University Hospital, Medical Devices Deals, 2011 to YTD 2017 9
National Taiwan University Hospital, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
National Taiwan University Hospital Forms Joint Venture with SynCore Biotech 11
Parexel International Enters Into Agreement With National Taiwan University Hospital 12
A*STAR Enters Into An Agreement With NTUH And CGMH 13
National Taiwan University Hospital, Key Competitors 14
National Taiwan University Hospital, Other Locations 15
National Taiwan University Hospital, Subsidiaries 15
National Taiwan University Hospital, Joint Venture 16

★海外企業調査レポート[National Taiwan University Hospital-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • NEC Corp (6701):企業の財務・戦略的SWOT分析
    NEC Corp (6701) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Toshiba America Electronic Components, Inc.:企業の戦略的SWOT分析
    Toshiba America Electronic Components, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …
  • Samsung Securities Co., Ltd. (016360):企業の財務・戦略的SWOT分析
    Samsung Securities Co., Ltd. (016360) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Becle S.A.B. de C.V. (CUERVO):企業の財務・戦略的SWOT分析
    Becle S.A.B. de C.V. (CUERVO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Minoryx Therapeutics sl-製薬・医療分野:企業M&A・提携分析
    Summary Minoryx Therapeutics sl (Minoryx) is a clinical stage biotechnology company that develops treatments for life threatening rare diseases. The company provides discovery, preclinical research, development and clinical trial programs. It develops ALD-MIN, morquio B and PCT drugs used for lysoso …
  • Vertex Pharmaceuticals Incorporated:企業の戦略・SWOT・財務情報
    Vertex Pharmaceuticals Incorporated - Strategy, SWOT and Corporate Finance Report Summary Vertex Pharmaceuticals Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Hermes International SA:企業の戦略・SWOT・財務分析
    Hermes International SA - Strategy, SWOT and Corporate Finance Report Summary Hermes International SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Eneco Refresh Ltd:企業の戦略・SWOT・財務分析
    Eneco Refresh Ltd - Strategy, SWOT and Corporate Finance Report Summary Eneco Refresh Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • DEINOVE SA (ALDEI):製薬・医療:M&Aディール及び事業提携情報
    Summary Deinove SA (Deinove) is a biotech company that discovers, develops and produces compounds. The company combines its biological assets and its metabolic engineering technology in three fields of application including healthcare, nutrition and cosmetics. Its healthcare application provides res …
  • MediWound Ltd (MDWD):製薬・医療:M&Aディール及び事業提携情報
    Summary MediWound Ltd (MediWound) is a biopharmaceutical company that on develops, manufactures and commercializes novel therapeutics based on its patented proteolytic enzyme technology. Its products address unmet needs in the areas of severe burns, chronic and other hard-to-heal wounds.The company’ …
  • Romark Laboratories LC:製薬・医療:M&Aディール及び事業提携情報
    Summary Romark Laboratories LC (Romark Laboratories) is a pharmaceutical company that discovers, develops and commercializes small molecules for the treatment of infectious diseases and cancers. The company develops Nitazoxanide, an oral suspension and tablets used for the treatment of intestinal pa …
  • Maritz Holdings Inc.:企業の戦略的SWOT分析
    Maritz Holdings Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Orezone Gold Corporation:企業の戦略・SWOT・財務情報
    Orezone Gold Corporation - Strategy, SWOT and Corporate Finance Report Summary Orezone Gold Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • BTG Plc (BTG):医療機器:M&Aディール及び事業提携情報
    Summary BTG plc (BTG) develops, manufactures and sells medicines for acute care, cancer and vascular diseases. The company develops specialty drugs including antidotes for snake envenomation and toxicity related to medicines used for heart conditions and cancer; interventional vascular products for …
  • Midatech Pharma Plc (MTPH):製薬・医療:M&Aディール及び事業提携情報
    Summary Midatech Pharma Plc (Midatech) is a pharmaceutical company that develops and commercializes products in oncology and other therapeutic areas. The company’s products include gelclair, oravig, soltamox and zuplenz. It conducts research and development programs in the areas of oncology, autoimm …
  • Salesforce.Com Inc (CRM):企業の財務・戦略的SWOT分析
    Salesforce.Com Inc (CRM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • National Petroleum Services Co (NAPESCO):石油・ガス:M&Aディール及び事業提携情報
    Summary National Petroleum Services Co (NAPESCO), a subsidiary of Qurain Petrochemical Industries Co, is an oil and gas service company that offers upstream and downstream services. The company's upstream oil field services includes filtration, well cementing services, downhole tools, casing hardwar …
  • FP Corporation:企業の戦略・SWOT・財務情報
    FP Corporation - Strategy, SWOT and Corporate Finance Report Summary FP Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Grupo Aeroportuario del Pacifico SAB de CV:企業の戦略・SWOT・財務情報
    Grupo Aeroportuario del Pacifico SAB de CV - Strategy, SWOT and Corporate Finance Report Summary Grupo Aeroportuario del Pacifico SAB de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Fluxys SA:企業の戦略的SWOT分析
    Fluxys SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆